Appraisal/NN
of/IN
potential/JJ
therapeutic/JJ
index/NN
of/IN
antioxidants/NNS
on/IN
the/DT
basis/NN
of/IN
their/PRP$
in/FW
vitro/FW
effects/NNS
on/IN
HIV/NN
replication/NN
in/IN
monocytes/NNS
and/CC
interleukin/NN
2-induced/JJ
lymphocyte/NN
proliferation/NN
./.

Antioxidant/JJ
molecules/NNS
have/VBP
been/VBN
suggested/VBN
to/TO
be/VB
of/IN
therapeutic/JJ
value/NN
in/IN
the/DT
treatment/NN
of/IN
HIV-infected/JJ
patients/NNS
./.
=====
To/TO
evaluate/VB
this/DT
possibility/NN
,/,
we/PRP
examined/VBD
in/FW
vitro/FW
the/DT
effects/NNS
of/IN
two/CD
types/NNS
of/IN
antioxidant/JJ
molecules/NNS
in/IN
terms/NNS
of/IN
inhibition/NN
of/IN
HIV/NN
replication/NN
in/IN
monocytes/NNS
,/,
one/CD
of/IN
the/DT
main/JJ
reservoirs/NNS
of/IN
HIV/NN
,/,
and/CC
also/RB
in/IN
terms/NNS
of/IN
modulation/NN
of/IN
the/DT
immune/JJ
competence/NN
as/IN
measured/VBN
by/IN
PBMC/NN
proliferation/NN
./.
=====
We/PRP
tested/VBD
the/DT
effects/NNS
of/IN
BHA/NN
,/,
a/DT
phenolic/JJ
,/,
lipid-soluble/JJ
,/,
chain-breaking/JJ
antioxidant/NN
,/,
and/CC
NAC/NN
,/,
a/DT
known/JJ
glutathione/NN
precursor/NN
with/IN
some/DT
direct/JJ
free-radical/JJ
scavenging/NN
properties/NNS
as/RB
well/RB
,/,
on/IN
the/DT
regulation/NN
of/IN
HIV-1/NN
expression/NN
in/IN
latently/RB
infected/JJ
U1/NN
cells/NNS
and/CC
in/IN
productively/RB
and/CC
chronically/RB
infected/JJ
U937/NN
cells/NNS
./.
=====
Both/DT
antioxidants/NNS
inhibited/VBD
TNF-/NN
or/CC
PMA-induced/JJ
NF-kappa/NN
B/NN
activity/NN
in/IN
U1/NN
cells/NNS
,/,
as/RB
well/RB
as/IN
the/DT
sustained/JJ
NF-kappa/NN
B/NN
activity/NN
permanently/RB
induced/VBN
by/IN
the/DT
virus/NN
itself/PRP
in/IN
chronically/RB
HIV-infected/JJ
U937/NN
cells/NNS
./.
=====
This/DT
resulted/VBD
in/IN
only/RB
a/DT
partial/JJ
inhibition/NN
of/IN
TNF-/NN
or/CC
PMA-induced/JJ
HIV/NN
replication/NN
in/IN
U1/NN
cells/NNS
,/,
and/CC
no/DT
detectable/JJ
effect/NN
on/IN
HIV/NN
replication/NN
in/IN
chronically/RB
infected/JJ
U937/NN
cells/NNS
./.
=====
This/DT
may/MD
be/VB
the/DT
first/JJ
limitation/NN
to/TO
potential/JJ
antiviral/JJ
effects/NNS
of/IN
antioxidant/JJ
therapies/NNS
./.
=====
Another/DT
limitation/NN
is/VBZ
that/IN
antioxidant/JJ
concentrations/NNS
high/JJ
enough/RB
to/TO
block/VB
NK-kappa/NN
B/NN
activation/NN
were/VBD
shown/VBN
to/TO
have/VB
a/DT
suppressive/JJ
effect/NN
on/IN
immune/JJ
functions/NNS
in/FW
vitro/FW
,/,
because/IN
NAC/NN
and/CC
BHA/NN
blocked/VBD
IL-2-induced/JJ
PBMC/NN
proliferation/NN
./.
=====
These/DT
data/NNS
warrant/VBP
prudence/NN
in/IN
the/DT
design/NN
of/IN
antioxidant-based/JJ
therapies/NNS
aimed/VBN
at/IN
suppressing/VBG
HIV/NN
replication/NN
./.